|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2009-5-15
|
|
pubmed:abstractText |
Bortezomib (Velcade) is a proteasome inhibitor used in the treatment of myeloma and other blood dyscrasias. We report the cases of two patients who developed a peculiar toxic rash suggestive of Sweet's syndrome while receiving bortezomib; one patient also presented giant mucous membrane ulcerations.
|
|
pubmed:language |
fre
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0151-9638
|
|
pubmed:author |
pubmed-author:BilletAA,
pubmed-author:ChabyGG,
pubmed-author:ChatelainDD,
pubmed-author:ChristopheOO,
pubmed-author:DadbanAA,
pubmed-author:DamajGG,
pubmed-author:LengletAA,
pubmed-author:LoiMM,
pubmed-author:MarolleauJ-PJP,
pubmed-author:RoyerRR,
pubmed-author:ThuillierDD,
pubmed-author:VaidaII,
pubmed-author:ViseuxVV
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
136
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
427-30
|
|
pubmed:meshHeading |
pubmed-meshheading:19442799-Antineoplastic Agents,
pubmed-meshheading:19442799-Biopsy,
pubmed-meshheading:19442799-Boronic Acids,
pubmed-meshheading:19442799-Colchicine,
pubmed-meshheading:19442799-Dexamethasone,
pubmed-meshheading:19442799-Female,
pubmed-meshheading:19442799-Humans,
pubmed-meshheading:19442799-Leukemia, Plasma Cell,
pubmed-meshheading:19442799-Lymphoma, Mantle-Cell,
pubmed-meshheading:19442799-Male,
pubmed-meshheading:19442799-Middle Aged,
pubmed-meshheading:19442799-Pyrazines,
pubmed-meshheading:19442799-Skin Ulcer,
pubmed-meshheading:19442799-Sweet Syndrome,
pubmed-meshheading:19442799-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
[Bortezomib-induced eruption: Sweet syndrome? Two case reports].
|
|
pubmed:affiliation |
Service de dermatologie, hôpital Sud, CHU d'Amiens, 80054 Amiens cedex 1, France.
|
|
pubmed:publicationType |
Journal Article,
English Abstract,
Case Reports
|
